As of 01.11.2022
6
Number of staff members
16
scientific publications
1
Objects of intellectual property
Name of the project: Clonal composition of tumor-infiltrating T lymphocytes as a forecasting and predictive marker in treatment of oncological illnesses
Research directions:
- Impact of immunotherapy using checkpoint inhibitors on clonal composition of functional subpopulations of T lymphocytes (observed in model mice and clinical samples);
- Fate of tumor-specific T lymphocytes in development of illness and during response to immunotherapy (in model mice);
- Aging of adaptive immunity, cancer, immunotherapy (in model mice);
- Clonality of CD4+, CD4+Treg, CD8+, and CD8+PD1+ Т lymphocytes in tumors and peripheral blood as a factor for forecasting in color cancer patients (in clinical samples).
izosimova a.v., yuzhakova d.v., skatova v.d., volchkova l.n., zagainova e.v., chudakov d.m., sharonov g.v.
Deciphering Repertoire of B16 Melanoma Reactive TCRs by Immunization, In Vitro Restimulation and Sequencing of IFNγ-Secreting T Cells. International Journal of Molecular Sciences. 2021 Sep (22, 18).
sharonov g.v., serebrovskaya e.o., yuzhakova d.v., britanova o.v., chudakov d.m.
В Cells, plasma cells and antibody repertoires in the tumour microenvironment. Nature Reviews Immunology. 2020 May (20, 5).
zhigalova e.a., izosimova a.i., yuzhakova d.v., volchkova l.n., shagina i.a., turchaninova m.a., serebrovskaya e.o., zagaynova e.v., chudakov d.m., sharonov g.v.
RNA-Seq-Based TCR profiling reveals persistently increased intratumoral clonality in responders to Anti-PD-1 therapy. Frontiers in Oncology. 2020 Apr (10).
yuzhakova d.v., volchkova l.n., pogorelyy m.v., serebrovskaya e.o., shagina i.a., bryushkova e.a., nakonechnaya t.o., izosimova a.v., zavyalova d.s., karabut m.m., izraelson m., samoylenko i.v., zagainov v.e., chudakov d.m., zagaynova e.v., sharonov g.v.
Measuring Intratumoral Heterogeneity of Immune Repertoires. Frontiers in Oncology. 2020 May (10).
isaeva o.i., sharonov g.v., serebrovskaya e.o., turchaninova m.a., zaretsky a.r., shugay m., chudakov d.m.
Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes. The Journal for ImmunoTherapy of Cancer. 2019 Oct (7, 1).
pogorelyy m.v., minervina a.a., shugay m., chudakov d.m., lebedev y.b., mora t., walczak a.m.
Detecting T cell receptors involved in immune responses from single repertoire snapshots. PLOS Biology. 2019 Jun (17, 6).
izraelson m., nakonechnaya t.o., moltedo b., egorov e.s., kasatskaya s.a., putintseva e.v., mamedov i.z., staroverov d.b., shemiakina i.i., zakharova m.y., davydov a.n., bolotin d.a., shugay m., chudakov d.m., rudensky a.y., britanovao.v.
Comparative analysis of murine T-cell receptor repertoires. Immunology. 2018 Feb (153, 2).
fan x., moltedo b., mendoza a., davydov a.n., faire m.b., mazutis l., sharma r., pe'er d., chudakov d.m., rudensky a.y.
CD49b defines functionally mature Treg cells that survey skin and vascular tissues. Journal of experimental medicine. 2018 Nov (215, 11).
bolotin d.a., poslavsky s., davydov a.n., frenkel f.e., fanchi l., zolotareva o.i., hemmers s., putintseva e.v., obraztsova a.s., shugay m., ataullakhanov r.i., rudensky a.y., schumacher t.n., chudakov d.m.
Antigen receptor repertoire profiling from RNA-seqdata. Nature Biotechnology. 2017 Oct (35, 10).
Hosting organization
|
Field of studies
|
City
|
Invited researcher
|
Time span of the project
|
---|---|---|---|---|
Laboratory of the Microangiopathic Mechanisms of Atherogenesis
Saint Petersburg State University - (SPbU) |
Fundamental medicine |
St. Petersburg |
Orlov Sergey Vladimirovich
Russia |
2022-2024 |
Research Laboratory «Molecular Immunology»
Kazan Federal University - (KFU) |
Fundamental medicine |
Kazan |
Simon Hans-Uwe
Switzerland, |
2021-2023 |
Laboratory for Theranostics in Urologic Oncology
I.M. Sechenov First Moscow State Medical University - (Sechenov University) |
Fundamental medicine |
Moscow |
Thierry Jean Paul Roger
France Khaidukov Yevgeniy ValeriyevichRussia |
2019-2021 |